Skip to main content
Premium Trial:

Request an Annual Quote

Kevin Conroy, Michelle Griffin

Adaptive Biotechnologies has appointed Kevin Conroy and Michelle Griffin to its board of directors. Board member Arnold Levine has transitioned to the firm's scientific advisory board.

Conroy currently serves as CEO and chairman of Exact Sciences. He has also served as president of Exact Sciences. Prior to joining Exact Sciences, Conroy served as president and CEO of Third Wave Technologies from 2005 to 2008.

Griffin currently serves as a board of director member and audit committee chair for Acer Therapeutics and HTG Molecular Diagnostics. Griffin previously served on the board of directors and audit committee chair for PhaseRx from 2016 to 2018, OncoGenex Pharmaceutics from 2008 to 2011, and Sonus Pharmaceuiticals from 2004 to 2008. She has also served as executive VP of operations and chief financial officer at OncoGenex from 2011 to 2013. She also held the positions of CEO, senior VP, and chief operating officer at Trubion Pharmaceuticals from 2009 to 2010, and acted as the firm's CFO from 2006 from 2009. Griffin also served as senior VP and CFO of Dendreon from 2005 to 2006.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.